S9 Ep7: Midweek Takeaway with James Short, CEO of Celadon Pharmaceuticals (AIM:CEL) #CEL
In this week's Midweek Takeaway, we’re joined by James Short, CEO of Celadon Pharmaceuticals, to discuss their exciting collaboration with Valeos Pharma in Denmark. James shares insights on how this partnership could double production capacity to 3 tonnes of medical-grade cannabis annually, potentially worth up to £30 million. We’ll also explore the financial impact, including the potential £1.7 million annual contribution to Celadon, and what this means for the company’s future. Tune in for an in-depth look at the numbers and strategy behind Celadon's growth in the European market!…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.